Hostname: page-component-7b7567c8c-tnkh4 Total loading time: 0 Render date: 2026-11-17T04:03:45.308Z Has data issue: false hasContentIssue false

Increased cardiovascular mortality in people with schizophrenia: a 24-year national register study

Published online by Cambridge University Press:  05 June 2017

J. Westman*
Affiliation:
Department of Neurobiology, Care Sciences, and Society, Division of Family Medicine, Karolinska Institutet, Stockholm, Sweden
S. V. Eriksson
Affiliation:
Department of Clinical Science, Danderyds Hospital, Stockholm, Sweden
M. Gissler
Affiliation:
Department of Neurobiology, Care Sciences, and Society, Division of Family Medicine, Karolinska Institutet, Stockholm, Sweden
J. Hällgren
Affiliation:
Department of Neurobiology, Care Sciences, and Society, Division of Family Medicine, Karolinska Institutet, Stockholm, Sweden
M. L. Prieto
Affiliation:
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USAFacultad de Medicina, Departamento de Psiquiatría, Universidad de los Andes, Santiago, Chile
W. V. Bobo
Affiliation:
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA
M. A. Frye
Affiliation:
Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA
D. Erlinge
Affiliation:
Department of Cardiology, Lunds Universitet, Lund, Sweden
L. Alfredsson
Affiliation:
Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden
U. Ösby
Affiliation:
Department of Neurobiology, Care Sciences, and Society, Division of Family Medicine, Karolinska Institutet, Stockholm, SwedenCenter for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden
*
*Address for correspondence: Dr J. Westman, Department of Neurobiology, Care Sciences, and Society, Division of Family Medicine, Karolinska Institutet, Alfred Nobels allé 12, SE-141 83 Huddinge, Sweden. (Email: jeanette.westman@ki.se)
Rights & Permissions [Opens in a new window]

Abstract

Aims

People who have schizophrenia die earlier from somatic diseases than do people in the general population, but information about cardiovascular deaths in people who have schizophrenia is limited. We analysed mortality in all age groups of people with schizophrenia by specific cardiovascular diseases (CVDs), focusing on five CVD diagnoses: coronary heart disease, acute myocardial infarction, cerebrovascular disease, heart failure and cardiac arrhythmias. We also compared hospital admissions for CVDs in people who had schizophrenia with hospital admissions for CVDs in the general population.

Methods

This national register study of 10 631 817 people in Sweden included 46 911 people who were admitted to the hospital for schizophrenia between 1 January 1987 and 31 December 2010. Information from national registers was used to identify people who had schizophrenia and obtain data about mortality, causes of death, medical diagnoses and hospitalisations.

Results

CVDs were the leading cause of death in people who had schizophrenia (5245 deaths), and CVDs caused more excess deaths than suicide. The mean age of CVD death was 10 years lower for people who had schizophrenia (70.5 years) than the general population (80.7 years). The mortality rate ratio (MRR) for CVDs in all people who had schizophrenia was 2.80 (95% confidence interval (CI) 2.73–2.88). In people aged 15–59 years who had schizophrenia, the MRR for CVDs was 6.16 (95% CI 5.79–6.54). In all people who had schizophrenia, the MRR for coronary heart disease was 2.83 (95% CI 2.73–2.94); acute myocardial infarction, 2.62 (95% CI 2.49–2.75); cerebrovascular disease, 2.4 (95% CI 2.25–2.55); heart failure, 3.25 (95% CI 2.94–3.6); and cardiac arrhythmias, 2.06 (95% CI 1.75–2.43). Hospital admissions for coronary heart disease were less frequent in people who had schizophrenia than in the general population (admission rate ratio, 0.88 (95% CI 0.83–0.94). In all age groups, survival after hospital admission for CVD was lower in people who had schizophrenia than in the general population.

Conclusions

People who had schizophrenia died 10 years earlier from CVDs than did people in the general population. For all five CVD diagnoses, mortality risk was higher for those with schizophrenia than those in the general population. Survival after hospitalisation for CVDs in people who had schizophrenia was comparable with that of people in the general population who were several decades older.

Information

Type
Original Articles
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © Cambridge University Press 2017
Figure 0

Table 1.Mortality rate ratios and excess deaths in people who had schizophrenia in Sweden from 1987 to 2010*

Figure 1

Table 2.Mortality rate ratios and excess deaths in people aged 15–59 years who had schizophrenia in Sweden from 1987 to 2010*

Figure 2

Fig. 1.Mortality rate ratio (MRR) and age by cause of death in people who had schizophrenia in Sweden between 1990 and 2010. The reference group is the general population of Sweden. The black line represents the MRR, and the grey shading represents the 95% CI.

Figure 3

Table 3.Relationship between age and cause of death in people who had schizophrenia in Sweden from 1987 to 2010*

Figure 4

Table 4.Relationship between age and specific cardiovascular causes of death in people who had schizophrenia in Sweden from 1987 to 2010*

Figure 5

Table 5.Hospital admissions in people who had schizophrenia in Sweden from 1990 t0 2010 after a 3-year washout period*

Figure 6

Fig. 2.Survival after first hospital admission for cardiovascular disease in people who had schizophrenia and people in the general population in Sweden.